OSE Immunotherapeutics SA
OSE Immunotherapeutics SA (ORPOF) Stock Competitors & Peer Comparison
See (ORPOF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ORPOF | $11.60 | +0.00% | 260.3M | -11.86 | -$0.98 | N/A |
| NONOF | $38.52 | +1.02% | 171.5B | 10.84 | $3.56 | +4.48% |
| CSLLY | $25.08 | +0.64% | 97.1B | 16.28 | $1.54 | +2.91% |
| UCBJF | $304.64 | +7.27% | 58.7B | 33.54 | $9.20 | +0.52% |
| UCBJY | $148.43 | +1.10% | 56.6B | 32.29 | $4.60 | +0.53% |
| ARGNF | $814.94 | +0.00% | 50.4B | 41.66 | $19.56 | N/A |
| CMXHF | $98.68 | +0.75% | 47.9B | 15.99 | $6.17 | +2.95% |
| WXIBF | $4.60 | +0.00% | 19B | 32.86 | $0.14 | N/A |
| IVBXF | $10.74 | +1.99% | 18.5B | 107.40 | $0.10 | N/A |
| WXXWY | $8.86 | +0.23% | 18B | 30.58 | $0.29 | N/A |
Stock Comparison
ORPOF vs NONOF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, NONOF has a market cap of 171.5B. Regarding current trading prices, ORPOF is priced at $11.60, while NONOF trades at $38.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas NONOF's P/E ratio is 10.84. In terms of profitability, ORPOF's ROE is N/A, compared to NONOF's ROE of +0.61%. Regarding short-term risk, ORPOF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check NONOF's competition here
ORPOF vs CSLLY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CSLLY has a market cap of 97.1B. Regarding current trading prices, ORPOF is priced at $11.60, while CSLLY trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CSLLY's P/E ratio is 16.28. In terms of profitability, ORPOF's ROE is N/A, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, ORPOF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check CSLLY's competition here
ORPOF vs UCBJF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, UCBJF has a market cap of 58.7B. Regarding current trading prices, ORPOF is priced at $11.60, while UCBJF trades at $304.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas UCBJF's P/E ratio is 33.54. In terms of profitability, ORPOF's ROE is N/A, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, ORPOF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check UCBJF's competition here
ORPOF vs UCBJY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, UCBJY has a market cap of 56.6B. Regarding current trading prices, ORPOF is priced at $11.60, while UCBJY trades at $148.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas UCBJY's P/E ratio is 32.29. In terms of profitability, ORPOF's ROE is N/A, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, ORPOF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check UCBJY's competition here
ORPOF vs ARGNF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ARGNF has a market cap of 50.4B. Regarding current trading prices, ORPOF is priced at $11.60, while ARGNF trades at $814.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ARGNF's P/E ratio is 41.66. In terms of profitability, ORPOF's ROE is N/A, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, ORPOF is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check ARGNF's competition here
ORPOF vs CMXHF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CMXHF has a market cap of 47.9B. Regarding current trading prices, ORPOF is priced at $11.60, while CMXHF trades at $98.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CMXHF's P/E ratio is 15.99. In terms of profitability, ORPOF's ROE is N/A, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, ORPOF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check CMXHF's competition here
ORPOF vs WXIBF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, ORPOF is priced at $11.60, while WXIBF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas WXIBF's P/E ratio is 32.86. In terms of profitability, ORPOF's ROE is N/A, compared to WXIBF's ROE of +0.10%. Regarding short-term risk, ORPOF is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check WXIBF's competition here
ORPOF vs IVBXF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, IVBXF has a market cap of 18.5B. Regarding current trading prices, ORPOF is priced at $11.60, while IVBXF trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas IVBXF's P/E ratio is 107.40. In terms of profitability, ORPOF's ROE is N/A, compared to IVBXF's ROE of +0.08%. Regarding short-term risk, ORPOF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check IVBXF's competition here
ORPOF vs WXXWY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, WXXWY has a market cap of 18B. Regarding current trading prices, ORPOF is priced at $11.60, while WXXWY trades at $8.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas WXXWY's P/E ratio is 30.58. In terms of profitability, ORPOF's ROE is N/A, compared to WXXWY's ROE of +0.10%. Regarding short-term risk, ORPOF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check WXXWY's competition here
ORPOF vs GNMSF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, GNMSF has a market cap of 16.9B. Regarding current trading prices, ORPOF is priced at $11.60, while GNMSF trades at $274.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas GNMSF's P/E ratio is 17.89. In terms of profitability, ORPOF's ROE is N/A, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, ORPOF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
ORPOF vs SBMFF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SBMFF has a market cap of 14.8B. Regarding current trading prices, ORPOF is priced at $11.60, while SBMFF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SBMFF's P/E ratio is 27.67. In terms of profitability, ORPOF's ROE is N/A, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, ORPOF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
ORPOF vs SBHMY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, ORPOF is priced at $11.60, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SBHMY's P/E ratio is 25.22. In terms of profitability, ORPOF's ROE is N/A, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, ORPOF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check SBHMY's competition here
ORPOF vs BRRGF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, ORPOF is priced at $11.60, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, ORPOF's ROE is N/A, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, ORPOF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check BRRGF's competition here
ORPOF vs AAVXF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, AAVXF has a market cap of 9.1B. Regarding current trading prices, ORPOF is priced at $11.60, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, ORPOF's ROE is N/A, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, ORPOF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
ORPOF vs ODTC Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, ORPOF is priced at $11.60, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ODTC's P/E ratio is 1.07. In terms of profitability, ORPOF's ROE is N/A, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ORPOF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
ORPOF vs AKBLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, AKBLF has a market cap of 6.5B. Regarding current trading prices, ORPOF is priced at $11.60, while AKBLF trades at $32.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas AKBLF's P/E ratio is 38.77. In terms of profitability, ORPOF's ROE is N/A, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, ORPOF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check AKBLF's competition here
ORPOF vs TRSBF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, TRSBF has a market cap of 6.1B. Regarding current trading prices, ORPOF is priced at $11.60, while TRSBF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas TRSBF's P/E ratio is 18.43. In terms of profitability, ORPOF's ROE is N/A, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, ORPOF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check TRSBF's competition here
ORPOF vs REGMF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, REGMF has a market cap of 5.6B. Regarding current trading prices, ORPOF is priced at $11.60, while REGMF trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas REGMF's P/E ratio is -32.26. In terms of profitability, ORPOF's ROE is N/A, compared to REGMF's ROE of +0.33%. Regarding short-term risk, ORPOF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check REGMF's competition here
ORPOF vs ABCZF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ORPOF is priced at $11.60, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ORPOF's ROE is N/A, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, ORPOF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
ORPOF vs LABFF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ORPOF is priced at $11.60, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ORPOF's ROE is N/A, compared to LABFF's ROE of +0.23%. Regarding short-term risk, ORPOF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
ORPOF vs SHJBF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SHJBF has a market cap of 4.1B. Regarding current trading prices, ORPOF is priced at $11.60, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SHJBF's P/E ratio is -20.00. In terms of profitability, ORPOF's ROE is N/A, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, ORPOF and SHJBF have similar daily volatility (0.00).Check SHJBF's competition here
ORPOF vs CAMRF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, ORPOF is priced at $11.60, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CAMRF's P/E ratio is 41.35. In terms of profitability, ORPOF's ROE is N/A, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, ORPOF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
ORPOF vs GNNSF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, GNNSF has a market cap of 3.3B. Regarding current trading prices, ORPOF is priced at $11.60, while GNNSF trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas GNNSF's P/E ratio is -37.25. In terms of profitability, ORPOF's ROE is N/A, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, ORPOF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check GNNSF's competition here
ORPOF vs ASPHF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, ORPOF is priced at $11.60, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, ORPOF's ROE is N/A, compared to ASPHF's ROE of -1.40%. Regarding short-term risk, ORPOF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
ORPOF vs TLPPF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, TLPPF has a market cap of 3B. Regarding current trading prices, ORPOF is priced at $11.60, while TLPPF trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas TLPPF's P/E ratio is -440.00. In terms of profitability, ORPOF's ROE is N/A, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, ORPOF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check TLPPF's competition here
ORPOF vs BRCTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, ORPOF is priced at $11.60, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BRCTF's P/E ratio is 26.85. In terms of profitability, ORPOF's ROE is N/A, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, ORPOF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check BRCTF's competition here
ORPOF vs ZLDPF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ZLDPF has a market cap of 2.9B. Regarding current trading prices, ORPOF is priced at $11.60, while ZLDPF trades at $40.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ZLDPF's P/E ratio is 2.95. In terms of profitability, ORPOF's ROE is N/A, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, ORPOF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check ZLDPF's competition here
ORPOF vs MPSYF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ORPOF is priced at $11.60, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ORPOF's ROE is N/A, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, ORPOF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check MPSYF's competition here
ORPOF vs GENSF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, GENSF has a market cap of 2.4B. Regarding current trading prices, ORPOF is priced at $11.60, while GENSF trades at $35.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas GENSF's P/E ratio is 38.26. In terms of profitability, ORPOF's ROE is N/A, compared to GENSF's ROE of +0.10%. Regarding short-term risk, ORPOF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check GENSF's competition here
ORPOF vs INCPF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, ORPOF is priced at $11.60, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas INCPF's P/E ratio is -77.50. In terms of profitability, ORPOF's ROE is N/A, compared to INCPF's ROE of -0.03%. Regarding short-term risk, ORPOF is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check INCPF's competition here
ORPOF vs BVNRY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BVNRY has a market cap of 2.2B. Regarding current trading prices, ORPOF is priced at $11.60, while BVNRY trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BVNRY's P/E ratio is 5.99. In terms of profitability, ORPOF's ROE is N/A, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, ORPOF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check BVNRY's competition here
ORPOF vs BVNKF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BVNKF has a market cap of 2.2B. Regarding current trading prices, ORPOF is priced at $11.60, while BVNKF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BVNKF's P/E ratio is 5.94. In terms of profitability, ORPOF's ROE is N/A, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, ORPOF and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here
ORPOF vs GLPGF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, ORPOF is priced at $11.60, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, ORPOF's ROE is N/A, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, ORPOF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
ORPOF vs ASCLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ASCLF has a market cap of 2B. Regarding current trading prices, ORPOF is priced at $11.60, while ASCLF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ASCLF's P/E ratio is -47.50. In terms of profitability, ORPOF's ROE is N/A, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, ORPOF and ASCLF have similar daily volatility (0.00).Check ASCLF's competition here
ORPOF vs MEOBF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, MEOBF has a market cap of 2B. Regarding current trading prices, ORPOF is priced at $11.60, while MEOBF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas MEOBF's P/E ratio is -15.50. In terms of profitability, ORPOF's ROE is N/A, compared to MEOBF's ROE of -0.18%. Regarding short-term risk, ORPOF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check MEOBF's competition here
ORPOF vs BIESF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ORPOF is priced at $11.60, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ORPOF's ROE is N/A, compared to BIESF's ROE of -0.07%. Regarding short-term risk, ORPOF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
ORPOF vs PHMMF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, ORPOF is priced at $11.60, while PHMMF trades at $92.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas PHMMF's P/E ratio is 40.08. In terms of profitability, ORPOF's ROE is N/A, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, ORPOF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
ORPOF vs ONTTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, ORPOF is priced at $11.60, while ONTTF trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ONTTF's P/E ratio is -8.15. In terms of profitability, ORPOF's ROE is N/A, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, ORPOF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check ONTTF's competition here
ORPOF vs HBMHF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, ORPOF is priced at $11.60, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, ORPOF's ROE is N/A, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, ORPOF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check HBMHF's competition here
ORPOF vs IDRSF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, IDRSF has a market cap of 1.3B. Regarding current trading prices, ORPOF is priced at $11.60, while IDRSF trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas IDRSF's P/E ratio is -7.94. In terms of profitability, ORPOF's ROE is N/A, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, ORPOF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check IDRSF's competition here
ORPOF vs SNBIF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, ORPOF is priced at $11.60, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, ORPOF's ROE is N/A, compared to SNBIF's ROE of -2.53%. Regarding short-term risk, ORPOF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check SNBIF's competition here
ORPOF vs CSPHF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CSPHF has a market cap of 1.3B. Regarding current trading prices, ORPOF is priced at $11.60, while CSPHF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CSPHF's P/E ratio is -21.52. In terms of profitability, ORPOF's ROE is N/A, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, ORPOF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check CSPHF's competition here
ORPOF vs CSBTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CSBTF has a market cap of 1.2B. Regarding current trading prices, ORPOF is priced at $11.60, while CSBTF trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CSBTF's P/E ratio is -195.87. In terms of profitability, ORPOF's ROE is N/A, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, ORPOF is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check CSBTF's competition here
ORPOF vs MDCLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, ORPOF is priced at $11.60, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, ORPOF's ROE is N/A, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, ORPOF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
ORPOF vs PPTDF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, ORPOF is priced at $11.60, while PPTDF trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas PPTDF's P/E ratio is -48.67. In terms of profitability, ORPOF's ROE is N/A, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, ORPOF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check PPTDF's competition here
ORPOF vs PHGUF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, ORPOF is priced at $11.60, while PHGUF trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas PHGUF's P/E ratio is -151.00. In terms of profitability, ORPOF's ROE is N/A, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, ORPOF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check PHGUF's competition here
ORPOF vs NURPF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, ORPOF is priced at $11.60, while NURPF trades at $8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas NURPF's P/E ratio is 48.35. In terms of profitability, ORPOF's ROE is N/A, compared to NURPF's ROE of +0.09%. Regarding short-term risk, ORPOF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
ORPOF vs BTTAY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, ORPOF is priced at $11.60, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ORPOF's ROE is N/A, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, ORPOF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check BTTAY's competition here
ORPOF vs TKBIF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, ORPOF is priced at $11.60, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, ORPOF's ROE is N/A, compared to TKBIF's ROE of N/A. Regarding short-term risk, ORPOF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check TKBIF's competition here
ORPOF vs INRLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, INRLF has a market cap of 877.7M. Regarding current trading prices, ORPOF is priced at $11.60, while INRLF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas INRLF's P/E ratio is -6.80. In terms of profitability, ORPOF's ROE is N/A, compared to INRLF's ROE of -0.59%. Regarding short-term risk, ORPOF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check INRLF's competition here
ORPOF vs BPMUF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, ORPOF is priced at $11.60, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, ORPOF's ROE is N/A, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, ORPOF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
ORPOF vs VBIZF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, ORPOF is priced at $11.60, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, ORPOF's ROE is N/A, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, ORPOF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check VBIZF's competition here
ORPOF vs IVEVF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, ORPOF is priced at $11.60, while IVEVF trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, ORPOF's ROE is N/A, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, ORPOF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check IVEVF's competition here
ORPOF vs CKDXF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, ORPOF is priced at $11.60, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ORPOF's ROE is N/A, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, ORPOF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check CKDXF's competition here
ORPOF vs GNFTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, GNFTF has a market cap of 544.4M. Regarding current trading prices, ORPOF is priced at $11.60, while GNFTF trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas GNFTF's P/E ratio is -12.09. In terms of profitability, ORPOF's ROE is N/A, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, ORPOF and GNFTF have similar daily volatility (0.00).Check GNFTF's competition here
ORPOF vs SOLTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SOLTF has a market cap of 492.3M. Regarding current trading prices, ORPOF is priced at $11.60, while SOLTF trades at $5.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SOLTF's P/E ratio is -6.25. In terms of profitability, ORPOF's ROE is N/A, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, ORPOF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check SOLTF's competition here
ORPOF vs RAONF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, ORPOF is priced at $11.60, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas RAONF's P/E ratio is -43.33. In terms of profitability, ORPOF's ROE is N/A, compared to RAONF's ROE of -0.26%. Regarding short-term risk, ORPOF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check RAONF's competition here
ORPOF vs GNFTY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, ORPOF is priced at $11.60, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, ORPOF's ROE is N/A, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, ORPOF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check GNFTY's competition here
ORPOF vs TBGNF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ORPOF is priced at $11.60, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ORPOF's ROE is N/A, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, ORPOF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
ORPOF vs CLVLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, ORPOF is priced at $11.60, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, ORPOF's ROE is N/A, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, ORPOF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
ORPOF vs AVCTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, AVCTF has a market cap of 420.2M. Regarding current trading prices, ORPOF is priced at $11.60, while AVCTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas AVCTF's P/E ratio is -6.40. In terms of profitability, ORPOF's ROE is N/A, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, ORPOF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
ORPOF vs PTCHF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, PTCHF has a market cap of 374.8M. Regarding current trading prices, ORPOF is priced at $11.60, while PTCHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas PTCHF's P/E ratio is 9.12. In terms of profitability, ORPOF's ROE is N/A, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, ORPOF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
ORPOF vs CLVLY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CLVLY has a market cap of 374M. Regarding current trading prices, ORPOF is priced at $11.60, while CLVLY trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CLVLY's P/E ratio is 16.20. In terms of profitability, ORPOF's ROE is N/A, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, ORPOF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here
ORPOF vs CYDY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CYDY has a market cap of 356.9M. Regarding current trading prices, ORPOF is priced at $11.60, while CYDY trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CYDY's P/E ratio is -9.36. In terms of profitability, ORPOF's ROE is N/A, compared to CYDY's ROE of +0.38%. Regarding short-term risk, ORPOF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check CYDY's competition here
ORPOF vs CMVLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, ORPOF is priced at $11.60, while CMVLF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CMVLF's P/E ratio is -13.64. In terms of profitability, ORPOF's ROE is N/A, compared to CMVLF's ROE of -0.32%. Regarding short-term risk, ORPOF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
ORPOF vs HLOSF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, HLOSF has a market cap of 318.2M. Regarding current trading prices, ORPOF is priced at $11.60, while HLOSF trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas HLOSF's P/E ratio is -16.18. In terms of profitability, ORPOF's ROE is N/A, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, ORPOF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check HLOSF's competition here
ORPOF vs NWBO Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, NWBO has a market cap of 313.5M. Regarding current trading prices, ORPOF is priced at $11.60, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas NWBO's P/E ratio is -3.39. In terms of profitability, ORPOF's ROE is N/A, compared to NWBO's ROE of +0.92%. Regarding short-term risk, ORPOF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check NWBO's competition here
ORPOF vs NGENF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, ORPOF is priced at $11.60, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas NGENF's P/E ratio is -15.19. In terms of profitability, ORPOF's ROE is N/A, compared to NGENF's ROE of -974.60%. Regarding short-term risk, ORPOF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check NGENF's competition here
ORPOF vs FGHQF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, ORPOF is priced at $11.60, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, ORPOF's ROE is N/A, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, ORPOF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
ORPOF vs PBBIF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ORPOF is priced at $11.60, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ORPOF's ROE is N/A, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ORPOF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
ORPOF vs SLNCF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SLNCF has a market cap of 283.4M. Regarding current trading prices, ORPOF is priced at $11.60, while SLNCF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SLNCF's P/E ratio is -4.44. In terms of profitability, ORPOF's ROE is N/A, compared to SLNCF's ROE of -4.29%. Regarding short-term risk, ORPOF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
ORPOF vs SPHDF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SPHDF has a market cap of 283.1M. Regarding current trading prices, ORPOF is priced at $11.60, while SPHDF trades at $20.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SPHDF's P/E ratio is -3.00. In terms of profitability, ORPOF's ROE is N/A, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, ORPOF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check SPHDF's competition here
ORPOF vs ORYZF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ORYZF has a market cap of 256.3M. Regarding current trading prices, ORPOF is priced at $11.60, while ORYZF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ORYZF's P/E ratio is -81.25. In terms of profitability, ORPOF's ROE is N/A, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, ORPOF is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check ORYZF's competition here
ORPOF vs HNSBF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, ORPOF is priced at $11.60, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas HNSBF's P/E ratio is -4.14. In terms of profitability, ORPOF's ROE is N/A, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, ORPOF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check HNSBF's competition here
ORPOF vs NWPHF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, ORPOF is priced at $11.60, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ORPOF's ROE is N/A, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, ORPOF and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
ORPOF vs CAIHF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, ORPOF is priced at $11.60, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, ORPOF's ROE is N/A, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, ORPOF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check CAIHF's competition here
ORPOF vs BOVNF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, ORPOF is priced at $11.60, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, ORPOF's ROE is N/A, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, ORPOF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check BOVNF's competition here
ORPOF vs FPHAF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ORPOF is priced at $11.60, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ORPOF's ROE is N/A, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, ORPOF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
ORPOF vs IPHYF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, IPHYF has a market cap of 186.5M. Regarding current trading prices, ORPOF is priced at $11.60, while IPHYF trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas IPHYF's P/E ratio is -3.16. In terms of profitability, ORPOF's ROE is N/A, compared to IPHYF's ROE of -6.59%. Regarding short-term risk, ORPOF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
ORPOF vs MLLCF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, MLLCF has a market cap of 185.5M. Regarding current trading prices, ORPOF is priced at $11.60, while MLLCF trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas MLLCF's P/E ratio is -2.36. In terms of profitability, ORPOF's ROE is N/A, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, ORPOF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check MLLCF's competition here
ORPOF vs KNTPF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, KNTPF has a market cap of 184M. Regarding current trading prices, ORPOF is priced at $11.60, while KNTPF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas KNTPF's P/E ratio is -6.54. In terms of profitability, ORPOF's ROE is N/A, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, ORPOF and KNTPF have similar daily volatility (0.00).Check KNTPF's competition here
ORPOF vs ADOCY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, ORPOF is priced at $11.60, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ORPOF's ROE is N/A, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, ORPOF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
ORPOF vs SCNLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SCNLF has a market cap of 161.5M. Regarding current trading prices, ORPOF is priced at $11.60, while SCNLF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SCNLF's P/E ratio is -15.56. In terms of profitability, ORPOF's ROE is N/A, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, ORPOF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check SCNLF's competition here
ORPOF vs BBIXF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BBIXF has a market cap of 157.7M. Regarding current trading prices, ORPOF is priced at $11.60, while BBIXF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BBIXF's P/E ratio is -13.50. In terms of profitability, ORPOF's ROE is N/A, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, ORPOF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check BBIXF's competition here
ORPOF vs AMGXF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, ORPOF is priced at $11.60, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ORPOF's ROE is N/A, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, ORPOF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check AMGXF's competition here
ORPOF vs SPHRY Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SPHRY has a market cap of 138.6M. Regarding current trading prices, ORPOF is priced at $11.60, while SPHRY trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SPHRY's P/E ratio is -55.00. In terms of profitability, ORPOF's ROE is N/A, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, ORPOF and SPHRY have similar daily volatility (0.00).Check SPHRY's competition here
ORPOF vs BRIBF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, ORPOF is priced at $11.60, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas BRIBF's P/E ratio is -2.35. In terms of profitability, ORPOF's ROE is N/A, compared to BRIBF's ROE of -0.07%. Regarding short-term risk, ORPOF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check BRIBF's competition here
ORPOF vs NDTP Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, NDTP has a market cap of 134.4M. Regarding current trading prices, ORPOF is priced at $11.60, while NDTP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas NDTP's P/E ratio is -2.80. In terms of profitability, ORPOF's ROE is N/A, compared to NDTP's ROE of -0.24%. Regarding short-term risk, ORPOF is less volatile compared to NDTP. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check NDTP's competition here
ORPOF vs HBPCF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, ORPOF is priced at $11.60, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, ORPOF's ROE is N/A, compared to HBPCF's ROE of -0.65%. Regarding short-term risk, ORPOF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
ORPOF vs TRGNF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, ORPOF is priced at $11.60, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, ORPOF's ROE is N/A, compared to TRGNF's ROE of -6.34%. Regarding short-term risk, ORPOF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check TRGNF's competition here
ORPOF vs SPHRF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, SPHRF has a market cap of 130.4M. Regarding current trading prices, ORPOF is priced at $11.60, while SPHRF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas SPHRF's P/E ratio is -31.06. In terms of profitability, ORPOF's ROE is N/A, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, ORPOF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here
ORPOF vs JWCTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, JWCTF has a market cap of 127.5M. Regarding current trading prices, ORPOF is priced at $11.60, while JWCTF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, ORPOF's ROE is N/A, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, ORPOF is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check JWCTF's competition here
ORPOF vs AAPGV Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ORPOF is priced at $11.60, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ORPOF's ROE is N/A, compared to AAPGV's ROE of -2.49%. Regarding short-term risk, ORPOF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check AAPGV's competition here
ORPOF vs MSCLF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, MSCLF has a market cap of 123.7M. Regarding current trading prices, ORPOF is priced at $11.60, while MSCLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas MSCLF's P/E ratio is 3.11. In terms of profitability, ORPOF's ROE is N/A, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, ORPOF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check MSCLF's competition here
ORPOF vs PSTTF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ORPOF is priced at $11.60, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ORPOF's ROE is N/A, compared to PSTTF's ROE of N/A. Regarding short-term risk, ORPOF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
ORPOF vs ATGGF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ATGGF has a market cap of 111.2M. Regarding current trading prices, ORPOF is priced at $11.60, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ATGGF's P/E ratio is N/A. In terms of profitability, ORPOF's ROE is N/A, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, ORPOF is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check ATGGF's competition here
ORPOF vs PRNAF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, PRNAF has a market cap of 109.8M. Regarding current trading prices, ORPOF is priced at $11.60, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas PRNAF's P/E ratio is -1.01. In terms of profitability, ORPOF's ROE is N/A, compared to PRNAF's ROE of -0.25%. Regarding short-term risk, ORPOF and PRNAF have similar daily volatility (0.00).Check PRNAF's competition here
ORPOF vs EPRXF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ORPOF is priced at $11.60, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ORPOF's ROE is N/A, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, ORPOF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ORPOF.Check EPRXF's competition here
ORPOF vs ADOIF Comparison March 2026
ORPOF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORPOF stands at 260.3M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, ORPOF is priced at $11.60, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORPOF currently has a P/E ratio of -11.86, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ORPOF's ROE is N/A, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ORPOF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here